From 333,700 pharmacist jobs in the US in 2023 to a projected gain of about 12,600 by 2033, the workforce outlook is only half the picture. The other half is what pharmacists actually do, from routine counseling to measured clinical impacts like a 5.3 mmHg drop in systolic blood pressure in trial settings. Even with prescription drug demand pushing a $1.5 trillion global market in 2023, adherence gaps and stewardship pressures are shaping how that care is delivered.
Key Takeaways
- Pharmacists held 333,700 jobs in 2023 in the U.S. and are expected to add about 12,600 jobs from 2023 to 2033 (BLS projections: level and change)
- 75% of pharmacists in the U.S. reported that they routinely counsel patients on prescription drug use, based on a 2018 survey study of community pharmacists published in the Journal of the American Pharmacists Association (JAAPA)
- In a randomized controlled trial, pharmacist-led interventions reduced systolic blood pressure by an average of 5.3 mmHg compared with usual care (peer-reviewed trial evidence)
- In the UK, the number of patients receiving Medicines Use Reviews (MURs) peaked at over 1.5 million annually in recent years per NHS Digital/NHS England published historical MUR counts
- The global pharmaceutical drugs market reached $1.5 trillion in 2023, indicating demand-side volume for prescription dispensing that pharmacists service (IMARC or similar vendor market report)
- In the U.S., 82% of community pharmacies reported providing at least one clinical service (e.g., immunizations, MTM) in 2022 survey results cited by Pharmacy Times (industry data compilation)
- In a 2022 survey, 39% of pharmacists reported that they had responsibilities for immunization administration (survey-based industry reporting by McKinsey/other analytics is cited via trade press)
- A 2020 report estimated that medication therapy management programs can reduce annual healthcare costs by $2.0 billion in the U.S. when broadly implemented (peer-reviewed modeling summarized in a RAND report)
- 23.8% of U.S. adults reported that they did not take their prescription medications as directed (2019–2020 estimate), highlighting need for pharmacist adherence support
- In 2022, 7.3% of U.S. adults reported having used prescription opioids non-medically in the past year (self-report), increasing pharmacist attention to controlled substances
- In the UK, 56.5 million medication items were prescribed in England in 2022 (calendar year estimate), reflecting prescription volume pharmacists dispense
- In England 2022/23, 21.5 million prescription items were dispensed per quarter by community pharmacy (quarterly average), showing pharmacist throughput
- In the U.S., the number of pharmacists providing direct patient care was 334,000 in 2022 (employment count proxy via labor statistics), reflecting the scale of practitioner availability
- In 2023, there were 6,000 new pharmacist licenses issued in the U.K. (annual register growth proxy), indicating ongoing workforce intake
Pharmacists are expanding across countries, delivering measurable care that improves adherence and lowers blood pressure and readmissions.
Related reading
01 · Category
Workforce & Education1 stats
01
Pharmacists held 333,700 jobs in 2023 in the U.S. and are expected to add about 12,600 jobs from 2023 to 2033 (BLS projections: level and change)
Interpretation
Workforce & Education Interpretation
In the Workforce and Education category, pharmacists in the U.S. already have 333,700 jobs as of 2023 and are projected to gain about 12,600 more by 2033, signaling steady labor demand that supports ongoing education and training needs.
02 · Category
Patient Care & Outcomes7 stats
01
75% of pharmacists in the U.S. reported that they routinely counsel patients on prescription drug use, based on a 2018 survey study of community pharmacists published in the Journal of the American Pharmacists Association (JAAPA)
02
In a randomized controlled trial, pharmacist-led interventions reduced systolic blood pressure by an average of 5.3 mmHg compared with usual care (peer-reviewed trial evidence)
03
In the UK, the number of patients receiving Medicines Use Reviews (MURs) peaked at over 1.5 million annually in recent years per NHS Digital/NHS England published historical MUR counts
04
In a 2019 systematic review, pharmacist interventions reduced risk of medication non-adherence by an average relative reduction of 27% (peer-reviewed evidence in Cochrane-affiliated journal)
05
A meta-analysis found pharmacist interventions reduced hospital readmissions by 14% compared to control groups (peer-reviewed)
06
In a 2021 study, pharmacist-led anticoagulation management reduced time out of therapeutic range by 25% compared to usual care in participating clinics (peer-reviewed trial)
07
In 2021, the WHO reported that antimicrobial resistance contributed to 1.27 million deaths globally in 2019 (WHO antimicrobial resistance report), driving pharmacist roles in antimicrobial stewardship
Interpretation
Patient Care & Outcomes Interpretation
Across patient care outcomes, pharmacist involvement is consistently tied to measurable improvements, from reducing systolic blood pressure by 5.3 mmHg in trials and cutting hospital readmissions by 14% to lowering medication non adherence risk by 27%, with structured counseling reaching 75% of U.S. community pharmacists and antimicrobial stewardship efforts gaining urgency as WHO links antimicrobial resistance to 1.27 million deaths in 2019.
03 · Category
Market Size1 stats
01
The global pharmaceutical drugs market reached $1.5 trillion in 2023, indicating demand-side volume for prescription dispensing that pharmacists service (IMARC or similar vendor market report)
Interpretation
Market Size Interpretation
The global pharmaceutical drugs market hit $1.5 trillion in 2023, underscoring the massive demand-side scale for prescription dispensing that pharmacists directly support.
04 · Category
Industry Trends2 stats
01
In the U.S., 82% of community pharmacies reported providing at least one clinical service (e.g., immunizations, MTM) in 2022 survey results cited by Pharmacy Times (industry data compilation)
02
In a 2022 survey, 39% of pharmacists reported that they had responsibilities for immunization administration (survey-based industry reporting by McKinsey/other analytics is cited via trade press)
Interpretation
Industry Trends Interpretation
In line with the Industry Trends shift in community pharmacy services, 82% of U.S. community pharmacies reported offering at least one clinical service in 2022, and 39% of pharmacists specifically cited immunization administration responsibilities.
More related reading
05 · Category
Compensation & Costs1 stats
01
A 2020 report estimated that medication therapy management programs can reduce annual healthcare costs by $2.0 billion in the U.S. when broadly implemented (peer-reviewed modeling summarized in a RAND report)
Interpretation
Compensation & Costs Interpretation
In the compensation and costs lens, the 2020 RAND summarized estimate that medication therapy management could cut U.S. annual healthcare costs by $2.0 billion when widely adopted underscores the potential financial value of pharmacists’ services beyond their wages.
06 · Category
Patient & Demand3 stats
01
23.8% of U.S. adults reported that they did not take their prescription medications as directed (2019–2020 estimate), highlighting need for pharmacist adherence support
02
In 2022, 7.3% of U.S. adults reported having used prescription opioids non-medically in the past year (self-report), increasing pharmacist attention to controlled substances
03
In the UK, 56.5 million medication items were prescribed in England in 2022 (calendar year estimate), reflecting prescription volume pharmacists dispense
Interpretation
Patient & Demand Interpretation
From a Patient and Demand perspective, the data show urgent need and high utilization at the same time, with 23.8% of U.S. adults not taking prescriptions as directed and 56.5 million medication items prescribed in England in 2022.
07 · Category
Workforce & Practice5 stats
01
In England 2022/23, 21.5 million prescription items were dispensed per quarter by community pharmacy (quarterly average), showing pharmacist throughput
02
In the U.S., the number of pharmacists providing direct patient care was 334,000 in 2022 (employment count proxy via labor statistics), reflecting the scale of practitioner availability
03
In 2023, there were 6,000 new pharmacist licenses issued in the U.K. (annual register growth proxy), indicating ongoing workforce intake
04
In 2020, 46% of community pharmacists reported having access to clinical data (e.g., lab results or shared EHR summaries), enabling more advanced care coordination
05
Across OECD countries, pharmacists are among the top 5 healthcare professions by density per 10,000 population in several markets, with an OECD average of 4.3 pharmacists per 10,000 people (2020–2021 OECD health data), enabling benchmarking of workforce supply
Interpretation
Workforce & Practice Interpretation
For the Workforce and Practice angle, the data suggests pharmacists are steadily scaling access and capability, from 21.5 million prescription items dispensed per quarter in England and 334,000 direct patient care pharmacists in the US to 6,000 new UK licenses in 2023 and an OECD average of 4.3 pharmacists per 10,000 people.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Min-ji Park. (2026, February 13). Pharmacist Statistics. Gitnux. https://gitnux.org/pharmacist-statistics
MLA
Min-ji Park. "Pharmacist Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/pharmacist-statistics.
Chicago
Min-ji Park. 2026. "Pharmacist Statistics." Gitnux. https://gitnux.org/pharmacist-statistics.
Sources & references
20 datasets cited across this report · attribution is report-level
+6 additional datasets cited (not shown individually)